Sandra Rojas-Caro's Net Worth
$0
Who is Sandra Rojas-Caro?
Sandra Rojas-Caro does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Aeglea BioTherapeutics, Inc., and NeuBase Therapeutics, Inc..
SEC CIK
Sandra Rojas-Caro's CIK is 0001674975
Past Insider Trading and Trends
2016 was Sandra Rojas-Caro's most active year for acquiring shares with 1 total transactions. Sandra Rojas-Caro's most active month to acquire stocks was the month of April. 2021 saw Sandra Rojas-Caro paying a total of $0.00 for 280,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeuBase Therapeutics, Inc. (NBSE) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||